Beta-3 adrenergic agonists are a class of drugs that selectively activate beta-3 adrenergic receptors, primarily found in adipose tissue and the bladder, to promote lipolysis and improve bladder function. These agonists are used in the treatment of conditions like overactive bladder and metabolic disorders, offering a targeted approach with potentially fewer side effects compared to non-selective adrenergic agents.